Data-Fusion for Epidemiological Analysis of Covid-19 Variants in UAE
Source abstract
Abstract
Since December 2019, a new pandemic has appeared causing a considerable negative global impact. The SARS-CoV-2 first emerged from China and transformed to a global pandemic within a short time. The virus was further observed to be spreading rapidly and mutating at a fast pace, with over 5,775 distinct variations of the virus observed globally (at the time of submitting this paper). Extensive research has been ongoing worldwide in order to get a better understanding of its behaviour, influence and more importantly, ways for reducing its impact. Data analytics has been playing a pivotal role in this research to obtain valuable insights into understanding and fighting against the spread of infection. However, this is time and resource intensive, making it difficult to observe and quickly identify the impact of mutations. Factors such as the spread or virulence could explain the three months delay in revealing the new virus variant in the UK. This paper presents an extensive correlation analysis of the effect caused by the different SARS-CoV-2 strains, and their influence on the population across diverse factors, such as propagation and fatality rates, during the peak of the pandemic, with a focus on two major countries in the Middle East, the United Arab Emirate (UAE) and the Kingdom of Saudi Arabia (KSA). This research aims to investigate the epidemiological behaviour of the Coronavirus’ genomic variants over time in the UAE, compared with the KSA, where correlation analysis is carried out for a number of cases, deaths and their statistical deviations. The results of the analysis highlight very interesting insights into the epidemiological impact of the Covid-19 genomic behaviour in both countries, which could lead to important actions taken to minimize the impact on wider public health, possibly saving lives, and the economy. For instance, our method identifies a potential correlation between a spike in the number of deaths per case of 5.5 observed in the UAE by March 24th, with the emergence of new genomic variants of the Coronavirus (G0_c, G0_e1 and G0_e2). Our proposed methodology can be instrumental in identifying and classifying new variations of the virus earlier, and possibly predicting foreseeable mutations through pattern analysis, hence creating proactive measures to control its spread, such as the recent case of the new virus variant, recently discovered in the UK.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: SARS-CoV-2 and COVID-19 Research · COVID-19 epidemiological studies · COVID-19 diagnosis using AI
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. An interactive web-based dashboard to track Covid-19 in real time10.1016/S1473-3099(20)30120-1 ↗
2. Variant analysis of Sars-cov-2 genomes10.2471/BLT.20.253591 ↗
3. Scientific research progress of Covid-19/Sars-cov-2 in the first five months10.1111/jcmm.15364 ↗
4. What we know so far: Covid-19 current clinical knowledge and research10.7861/clinmed.2019-coron ↗
5. Covid-19: Four fifths of cases are asymptomatic, China figures indicate
6. Mobile laboratory routing problem for Covid-19 testing considering limited capacities of hospitals
7. Covid-19: The case for health-care worker screening to prevent hospital transmission
8. Multisystem inflammatory syndrome in children: A systematic review10.1016/j.eclinm.2020.100527 ↗
9. Neurochemical evidence of astrocytic and neuronal injury commonly found in Covid-1910.1212/WNL.0000000000010111 ↗
10. Management of post-acute Covid-19 in primary care
11. Making sense of mutation: What D614G means for the Covid-19 pandemic remains unclear10.1016/j.cell.2020.06.040 ↗
12. Emergence of genomic diversity and recurrent mutations in SARS-CoV-210.1016/j.meegid.2020.104351 ↗
13. Crystal structure of the S1 subunit n-terminal domain from DcCoV UAE-HKU23 spike protein10.1016/j.virol.2019.06.015 ↗
14. A comprehensive literature review on the clinical presentation, and management of the pandemic Coronavirus disease 2019 (Covid-19)
15. The origin, transmission and clinical therapies on Coronavirus disease 2019 (Covid-19) outbreak–an update on the status10.1186/s40779-020-00240-0 ↗
16. The hallmarks of Covid-19 disease10.1371/journal.ppat.1008536 ↗
17. Clinical and biological insights from viral genome sequencing10.1038/nrmicro.2016.182 ↗
18. Real-time RT-PCR in Covid-19 detection: Issues affecting the results10.1080/14737159.2020.1757437 ↗
19. Diagnostic tools for Coronavirus disease (Covid-19): Comparing CT and RT-PCR viral nucleic acid testing10.2214/AJR.20.23418 ↗
20. Benchmarking methodology for selection of optimal Covid-19 diagnostic model based on entropy and TOPSIS methods10.1109/ACCESS.2020.2995597 ↗
21. Genomic and molecular analysis of SARS-CoV-2 and the possible strategies of Covid-19 treatment-a review
22. Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the Covid-19 virus10.1016/j.cell.2020.06.043 ↗
23. A virus that has gone viral: Amino acid mutation in s protein of Indian isolate of Coronavirus Covid-19 might impact receptor binding and thus infectivity10.1042/BSR20201312 ↗
24. A review of fog computing and machine learning: Concepts applications
25. Covid-CheXNet: Hybrid deep learning framework for identifying Covid-19 virus in X-rays images
26. Roles of mutation and selection in speciation: From Hugo de Vries to the modern genomic era10.1093/gbe/evr028 ↗
27. A review on multiple sequence alignment from the perspective of genetic algorithm10.1016/j.ygeno.2017.06.007 ↗
28. Phylogenetic trees and networks can serve as powerful and complementary approaches for analysis of genomic data10.1093/sysbio/syz056 ↗
29. SARS-CoV-2 whole genome amplification and sequencing for effective population-based surveillance and control of viral transmission10.1093/clinchem/hvaa187 ↗
30. Mutations on Covid-19 diagnostic targets10.1016/j.ygeno.2020.09.028 ↗
31. Accelerating genomics-based surveillance for Covid-19 response in Africa10.1016/S2666-5247(20)30117-8 ↗
32. Variant analysis of SARS-CoV-2 genomes in the middle east10.1016/j.micpath.2021.104741 ↗
33. Public Health England, “Covid-19 (SARS-CoV-2): Information about the new virus variant,” 2020. [Online]. Available: https://www.gov.uk/government/news/covid-19-sars-cov-2-information-about-the-new-virus-variant.
34. After the first wave of Covid-19: Reflections from Italy10.1097/INF.0000000000002806 ↗
35. GISAID: Global initiative on sharing all influenza data–from vision to reality10.2807/1560-7917.ES.2017.22.13.30494 ↗
36. NCBI viral genomes resource10.1093/nar/gku1207 ↗
37. MEGA X: Molecular evolutionary genetics analysis across computing platforms10.1093/molbev/msy096 ↗
38. A cross-country database of COVID-19 testing10.1038/s41597-020-00688-8 ↗
39. T. Hale, S. Webster, A. Petherick, T. Phillips, B. Kira et al., “Oxford Covid-19 government response tracker, Blavatnik School of Government,” 2020. [Online]. Available: https://www.bsg.ox.ac.uk/research/research-projects/Coronavirus-government-response-tracker.
40. MUSCLE: Multiple sequence alignment with high accuracy and high throughput10.1093/nar/gkh340 ↗
41. Multiple early introductions of SARS-CoV-2 into a global travel hub in the middle east10.1038/s41598-020-74666-w ↗
42. Impact of international travel and border control measures on the global spread of the novel 2019 Coronavirus outbreak
43. The incubation period of coronavirus disease 2019 (Covid-19) from publicly reported confirmed cases: Estimation and application10.7326/M20-0504 ↗
44. Mathematical modeling of Covid-19 fatality trends: Death kinetics law versus infection-to-death delay rule10.1016/j.chaos.2020.109891 ↗
45. A cross-country database of Covid-19 testing10.1038/s41597-020-00688-8 ↗
46. Population-Worldometer, 2020. [Online]. Available: https://www.worldometers.info/population/.
47. Covid-19 deaths: Are we sure it is pneumonia? please, autopsy, autopsy, autopsy!10.3390/jcm9051259 ↗
48. Assessing Risk Factors, “Centers for disease control and prevention,” 2020. [Online]. Available: https://www.cdc.gov/Coronavirus/2019-ncov/covid-data/investigations-discovery/assessing-risk-factors.html.
49. People with Certain Medical Conditions, “Centers for disease control and prevention,” 2020. [Online]. Available: https://www.cdc.gov/Coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html.